Krueger Christopher W's Form 4 filing
Ventyx Biosciences, Inc. (VTYX) · filed Sep 7, 2023
- Accession no.
- 0001209191-23-048623
- Filed
- Sep 7, 2023
- Trade date
- Sep 5, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $489.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Krueger Christopher WCIK 0001394208 | Officer (Chief Business Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | Common Stock | MOption exerciseAcquired | +15,000 | $8.04 | +$120,600 | 291,548 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −10,431 | $32.25F2 | −$336,399.75 | 281,117 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −4,546 | $33.42F3 | −$151,927.32 | 276,571 | Direct | |
| Sep 5, 2023 | Common Stock | SSaleDisposed | −23 | $33.97 | −$781.31 | 276,548 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2023 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 119,371 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 10,431 shares sold in the price range of $31.9623 to $32.96. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 4,546 shares sold in the price range of $32.97 to $33.96. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.